Renovaro Inc. - Common Stock (NQ: RENB )
1.560
+0.040
(+2.63%)
Streaming Delayed Price
Updated: 10:02 AM EDT, Jul 11, 2024
Add to My Watchlist
Press Releases about Renovaro Inc. - Common Stock![]() ![]()
Study Shows Ongoing Benefits Once Immunotherapy Stops
January 02, 2024
Researchers Harnessing Immune System to Fight Cancer More Effectively
December 07, 2023
Study Says Patients on Gene Therapy Need Long-Term Monitoring
November 27, 2023
![]()
Unlocking AI investment opportunities in healthcare
November 16, 2023
Via MarketBeat
Exposures
Artificial Intelligence
How Immunotherapy Is Cementing a Role in Cancer Treatment
November 13, 2023
Alarming Data Highlights Gaps in Treating People with Chronic HBV
November 01, 2023
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|